NCT03243890View on ClinicalTrials.gov

The Aortic Valve DECalcification (AVADEC) Trial

NACompletedINTERVENTIONAL
Enrollment

389

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
Aortic Valve StenosisMultidetector Computed TomographyVitamin K 2Randomised Clinical Trial
Interventions
DIETARY_SUPPLEMENT

Menaquinone-7 720 µg/day including the recommended daily dose of vitamin D (25 µg/day).

Half of the patients are randomized to supplementation with MK-7 (720 µg/day) including the recommended daily dose of vitamin D (25 µg/day).

DIETARY_SUPPLEMENT

Placebo

Half of the patients are randomized to placebo treatment (no active treatment).

Trial Locations (1)

DK-5000

Department of Cardiology, Odense University Hospital, Odense

All Listed Sponsors
lead

Axel Diederichsen

OTHER

NCT03243890 - The Aortic Valve DECalcification (AVADEC) Trial | Biotech Hunter | Biotech Hunter